{"id":22199,"date":"2024-09-06T10:50:35","date_gmt":"2024-09-06T10:50:35","guid":{"rendered":"https:\/\/www.centrocliniconemo.it\/?post_type=studi-clinici&#038;p=22199"},"modified":"2024-09-06T10:54:43","modified_gmt":"2024-09-06T10:54:43","slug":"strength","status":"publish","type":"studi-clinici","link":"https:\/\/www.centrocliniconemo.it\/en\/cura-e-ricerca\/studi-clinici\/strength\/","title":{"rendered":"STRENGTH"},"featured_media":22168,"parent":0,"menu_order":0,"template":"","class_list":["post-22199","studi-clinici","type-studi-clinici","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>STRENGTH - Centro Clinico NeMO<\/title>\n<meta name=\"description\" content=\"Phase IIIb, open-label, single-arStudio multicentrico di Fase IIIb, in aperto, a braccio singolo, per valutare valutare la sicurezza, la tollerabilit\u00e0 e l&#039;efficacia di OAV101 somministrato per via intratecale a partecipanti di et\u00e0 compresa tra 2 e &lt; 18 anni affetti da atrofia muscolare spinale (SMA) che hanno interrotto il trattamento con nusinersen (Spinraza\u00ae) o risdiplam (Evrysdi\u00ae)m, multi-center study to evaluate the safety, tolerability and efficacy of OAV101 administered intrathecally (1.2 x 1014 vector genomes) to participants 2 to &lt; 18 years of age with spinal muscular atrophy (SMA) who have discontinued treatment with nusinersen (Spinraza\u00ae) or risdiplam (Evrysdi\u00ae)\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centrocliniconemo.it\/en\/cura-e-ricerca\/studi-clinici\/strength\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"STRENGTH\" \/>\n<meta property=\"og:description\" content=\"Studio multicentrico di Fase IIIb, in aperto, a braccio singolo, per valutare valutare la sicurezza, la tollerabilit\u00e0 e l&#039;efficacia di OAV101 somministrato per via intratecale a partecipanti di et\u00e0 compresa tra 2 e &lt; 18 anni affetti da atrofia muscolare spinale (SMA) che hanno interrotto il trattamento con nusinersen (Spinraza\u00ae) o risdiplam (Evrysdi\u00ae)\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centrocliniconemo.it\/en\/cura-e-ricerca\/studi-clinici\/strength\/\" \/>\n<meta property=\"og:site_name\" content=\"Centro Clinico NeMO\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CentroNEMOItalia\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-06T10:54:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centrocliniconemo.it\/wp-content\/uploads\/2024\/08\/nemo-brescia-bando-riicerca-assegni-borsa-studio-professor-filosto-02.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"STRENGTH\" \/>\n<meta name=\"twitter:description\" content=\"Studio multicentrico di Fase IIIb, in aperto, a braccio singolo, per valutare valutare la sicurezza, la tollerabilit\u00e0 e l&#039;efficacia di OAV101 somministrato per via intratecale a partecipanti di et\u00e0 compresa tra 2 e &lt; 18 anni affetti da atrofia muscolare spinale (SMA) che hanno interrotto il trattamento con nusinersen (Spinraza\u00ae) o risdiplam (Evrysdi\u00ae)\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.centrocliniconemo.it\/wp-content\/uploads\/2024\/08\/nemo-brescia-bando-riicerca-assegni-borsa-studio-professor-filosto-02.jpg\" \/>\n<meta name=\"twitter:site\" content=\"@CentroNemo\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/en\\\/cura-e-ricerca\\\/studi-clinici\\\/strength\\\/\",\"url\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/en\\\/cura-e-ricerca\\\/studi-clinici\\\/strength\\\/\",\"name\":\"STRENGTH - Centro Clinico NeMO\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/en\\\/cura-e-ricerca\\\/studi-clinici\\\/strength\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/en\\\/cura-e-ricerca\\\/studi-clinici\\\/strength\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/nemo-brescia-bando-riicerca-assegni-borsa-studio-professor-filosto-02.jpg\",\"datePublished\":\"2024-09-06T10:50:35+00:00\",\"dateModified\":\"2024-09-06T10:54:43+00:00\",\"description\":\"Phase IIIb, open-label, single-arStudio multicentrico di Fase IIIb, in aperto, a braccio singolo, per valutare valutare la sicurezza, la tollerabilit\u00e0 e l'efficacia di OAV101 somministrato per via intratecale a partecipanti di et\u00e0 compresa tra 2 e &lt; 18 anni affetti da atrofia muscolare spinale (SMA) che hanno interrotto il trattamento con nusinersen (Spinraza\u00ae) o risdiplam (Evrysdi\u00ae)m, multi-center study to evaluate the safety, tolerability and efficacy of OAV101 administered intrathecally (1.2 x 1014 vector genomes) to participants 2 to &lt; 18 years of age with spinal muscular atrophy (SMA) who have discontinued treatment with nusinersen (Spinraza\u00ae) or risdiplam (Evrysdi\u00ae)\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/en\\\/cura-e-ricerca\\\/studi-clinici\\\/strength\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centrocliniconemo.it\\\/en\\\/cura-e-ricerca\\\/studi-clinici\\\/strength\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/en\\\/cura-e-ricerca\\\/studi-clinici\\\/strength\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/nemo-brescia-bando-riicerca-assegni-borsa-studio-professor-filosto-02.jpg\",\"contentUrl\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/nemo-brescia-bando-riicerca-assegni-borsa-studio-professor-filosto-02.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/en\\\/cura-e-ricerca\\\/studi-clinici\\\/strength\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clinical studies\",\"item\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/en\\\/care-and-research\\\/clinical-studies\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"STRENGTH\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/en\\\/\",\"name\":\"Centro Clinico NeMO\",\"description\":\"Il paziente al centro\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/en\\\/#organization\",\"name\":\"Centro Clinico NeMO - Fondazione Serena Onlus\",\"url\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/logo-nemo.svg\",\"contentUrl\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/logo-nemo.svg\",\"width\":272,\"height\":109.142,\"caption\":\"Centro Clinico NeMO - Fondazione Serena Onlus\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centrocliniconemo.it\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/CentroNEMOItalia\",\"https:\\\/\\\/x.com\\\/CentroNemo\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centrocliniconemo\\\/\",\"https:\\\/\\\/www.instagram.com\\\/centrocliniconemo\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"STRENGTH - Centro Clinico NeMO","description":"Phase IIIb, open-label, single-arStudio multicentrico di Fase IIIb, in aperto, a braccio singolo, per valutare valutare la sicurezza, la tollerabilit\u00e0 e l'efficacia di OAV101 somministrato per via intratecale a partecipanti di et\u00e0 compresa tra 2 e &lt; 18 anni affetti da atrofia muscolare spinale (SMA) che hanno interrotto il trattamento con nusinersen (Spinraza\u00ae) o risdiplam (Evrysdi\u00ae)m, multi-center study to evaluate the safety, tolerability and efficacy of OAV101 administered intrathecally (1.2 x 1014 vector genomes) to participants 2 to &lt; 18 years of age with spinal muscular atrophy (SMA) who have discontinued treatment with nusinersen (Spinraza\u00ae) or risdiplam (Evrysdi\u00ae)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centrocliniconemo.it\/en\/cura-e-ricerca\/studi-clinici\/strength\/","og_locale":"en_US","og_type":"article","og_title":"STRENGTH","og_description":"Studio multicentrico di Fase IIIb, in aperto, a braccio singolo, per valutare valutare la sicurezza, la tollerabilit\u00e0 e l'efficacia di OAV101 somministrato per via intratecale a partecipanti di et\u00e0 compresa tra 2 e &lt; 18 anni affetti da atrofia muscolare spinale (SMA) che hanno interrotto il trattamento con nusinersen (Spinraza\u00ae) o risdiplam (Evrysdi\u00ae)","og_url":"https:\/\/www.centrocliniconemo.it\/en\/cura-e-ricerca\/studi-clinici\/strength\/","og_site_name":"Centro Clinico NeMO","article_publisher":"https:\/\/www.facebook.com\/CentroNEMOItalia","article_modified_time":"2024-09-06T10:54:43+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.centrocliniconemo.it\/wp-content\/uploads\/2024\/08\/nemo-brescia-bando-riicerca-assegni-borsa-studio-professor-filosto-02.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_title":"STRENGTH","twitter_description":"Studio multicentrico di Fase IIIb, in aperto, a braccio singolo, per valutare valutare la sicurezza, la tollerabilit\u00e0 e l'efficacia di OAV101 somministrato per via intratecale a partecipanti di et\u00e0 compresa tra 2 e &lt; 18 anni affetti da atrofia muscolare spinale (SMA) che hanno interrotto il trattamento con nusinersen (Spinraza\u00ae) o risdiplam (Evrysdi\u00ae)","twitter_image":"https:\/\/www.centrocliniconemo.it\/wp-content\/uploads\/2024\/08\/nemo-brescia-bando-riicerca-assegni-borsa-studio-professor-filosto-02.jpg","twitter_site":"@CentroNemo","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.centrocliniconemo.it\/en\/cura-e-ricerca\/studi-clinici\/strength\/","url":"https:\/\/www.centrocliniconemo.it\/en\/cura-e-ricerca\/studi-clinici\/strength\/","name":"STRENGTH - Centro Clinico NeMO","isPartOf":{"@id":"https:\/\/www.centrocliniconemo.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.centrocliniconemo.it\/en\/cura-e-ricerca\/studi-clinici\/strength\/#primaryimage"},"image":{"@id":"https:\/\/www.centrocliniconemo.it\/en\/cura-e-ricerca\/studi-clinici\/strength\/#primaryimage"},"thumbnailUrl":"https:\/\/www.centrocliniconemo.it\/wp-content\/uploads\/2024\/08\/nemo-brescia-bando-riicerca-assegni-borsa-studio-professor-filosto-02.jpg","datePublished":"2024-09-06T10:50:35+00:00","dateModified":"2024-09-06T10:54:43+00:00","description":"Phase IIIb, open-label, single-arStudio multicentrico di Fase IIIb, in aperto, a braccio singolo, per valutare valutare la sicurezza, la tollerabilit\u00e0 e l'efficacia di OAV101 somministrato per via intratecale a partecipanti di et\u00e0 compresa tra 2 e &lt; 18 anni affetti da atrofia muscolare spinale (SMA) che hanno interrotto il trattamento con nusinersen (Spinraza\u00ae) o risdiplam (Evrysdi\u00ae)m, multi-center study to evaluate the safety, tolerability and efficacy of OAV101 administered intrathecally (1.2 x 1014 vector genomes) to participants 2 to &lt; 18 years of age with spinal muscular atrophy (SMA) who have discontinued treatment with nusinersen (Spinraza\u00ae) or risdiplam (Evrysdi\u00ae)","breadcrumb":{"@id":"https:\/\/www.centrocliniconemo.it\/en\/cura-e-ricerca\/studi-clinici\/strength\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centrocliniconemo.it\/en\/cura-e-ricerca\/studi-clinici\/strength\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.centrocliniconemo.it\/en\/cura-e-ricerca\/studi-clinici\/strength\/#primaryimage","url":"https:\/\/www.centrocliniconemo.it\/wp-content\/uploads\/2024\/08\/nemo-brescia-bando-riicerca-assegni-borsa-studio-professor-filosto-02.jpg","contentUrl":"https:\/\/www.centrocliniconemo.it\/wp-content\/uploads\/2024\/08\/nemo-brescia-bando-riicerca-assegni-borsa-studio-professor-filosto-02.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.centrocliniconemo.it\/en\/cura-e-ricerca\/studi-clinici\/strength\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centrocliniconemo.it\/en\/"},{"@type":"ListItem","position":2,"name":"Clinical studies","item":"https:\/\/www.centrocliniconemo.it\/en\/care-and-research\/clinical-studies\/"},{"@type":"ListItem","position":3,"name":"STRENGTH"}]},{"@type":"WebSite","@id":"https:\/\/www.centrocliniconemo.it\/en\/#website","url":"https:\/\/www.centrocliniconemo.it\/en\/","name":"Centro Clinico NeMO","description":"Il paziente al centro","publisher":{"@id":"https:\/\/www.centrocliniconemo.it\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centrocliniconemo.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.centrocliniconemo.it\/en\/#organization","name":"Centro Clinico NeMO - Fondazione Serena Onlus","url":"https:\/\/www.centrocliniconemo.it\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.centrocliniconemo.it\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.centrocliniconemo.it\/wp-content\/uploads\/2023\/03\/logo-nemo.svg","contentUrl":"https:\/\/www.centrocliniconemo.it\/wp-content\/uploads\/2023\/03\/logo-nemo.svg","width":272,"height":109.142,"caption":"Centro Clinico NeMO - Fondazione Serena Onlus"},"image":{"@id":"https:\/\/www.centrocliniconemo.it\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CentroNEMOItalia","https:\/\/x.com\/CentroNemo","https:\/\/www.linkedin.com\/company\/centrocliniconemo\/","https:\/\/www.instagram.com\/centrocliniconemo\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.centrocliniconemo.it\/en\/wp-json\/wp\/v2\/studi-clinici\/22199","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centrocliniconemo.it\/en\/wp-json\/wp\/v2\/studi-clinici"}],"about":[{"href":"https:\/\/www.centrocliniconemo.it\/en\/wp-json\/wp\/v2\/types\/studi-clinici"}],"version-history":[{"count":0,"href":"https:\/\/www.centrocliniconemo.it\/en\/wp-json\/wp\/v2\/studi-clinici\/22199\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.centrocliniconemo.it\/en\/wp-json\/wp\/v2\/media\/22168"}],"wp:attachment":[{"href":"https:\/\/www.centrocliniconemo.it\/en\/wp-json\/wp\/v2\/media?parent=22199"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}